IP Library › Granted Patent US 11,981,964
Granted Patent B2
US 11,981,964 · App. 17/385,232 · Granted May 14, 2024

Substituted coumarin dyes and uses as fluorescent labels

Inventors: Nikolai Nikolaevich Romanov (Cambridge, GB); Michael Callingham (Cambridge, GB); Carole Anastasi (Cambridge, GB); Patrick Mccauley (Cambridge, GB); Niall Hynes (Cambridge, GB); Natasha Crake (Cambridge, GB); Xiaolin Wu (Cambridge, GB); Xiaohai Liu (Cambridge, GB)
Assignee: Illumina Cambridge Limited
C12Q1/6876C07D405/14C07D407/04C07D409/04C07D409/14C07D413/04C07D417/04C07D417/14C09B57/02C12Q1/6869G01N21/6428G01N2021/6439
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,981,964
App. No.
17/385,232
Granted
May 14, 2024
Kind
B2
Abstract

The present application relates to substituted coumarin derivatives and their uses as fluorescent labels. These compounds may be used as fluorescent labels for nucleotides in nucleic acid sequencing applications.

Claims (39)

1. A compound of Formula (II) or (II′), or a salt or mesomeric form thereof:

wherein X is S, O, or NR a ;

Y is O or NH;

each R 1 , R 2 , R 3 and R 5 is independently H, optionally substituted C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 1 -C 6 hydroxy alkyl, (C 1 -C 6 alkoxy)(C 1 -C 6 alkyl), optionally substituted amino, halo, cyano, hydroxy, nitro, sulfonyl, sulfino, sulfo, sulfonate, S-sulfonamido, N-sulfonamido, optionally substituted C 3 -C 10 carbocyclyl, optionally substituted C 6 -C 10 aryl, optionally substituted 5 to 10 membered heteroaryl, or optionally substituted 3 to 10 membered heterocyclyl;

R 4 is —NR b R c , halo, —OR d or —OS(O) 2 R d ;

each of R 6 and R 7 is independently H, carboxyl, —C(O)NR b R c , —C(O)OR d , C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, halo, optionally substituted amino, N-sulfonamido, sulfonyl, S-sulfonamido, hydroxy, cyano, nitro, optionally substituted phenyl, optionally substituted C 3 -C 8 carbocyclyl, optionally substituted 5 to 10 membered heteroaryl, or optionally substituted 3 to 10 membered heterocyclyl; or R 6 and R 7 in Formula (II) together with the atoms to which they are attached form an optionally substituted C 5 -C 8 carbocyclyl or an optionally substituted 5 to 8 membered heterocyclyl;

R a is H or C 1 -C 6 alkyl;

each R b and R c is independently H, C 1 -C 6 alkyl, or substituted C 1 -C 6 alkyl; or R b and R c together with the nitrogen atom to which they are attached form an optionally substituted 4 to 10 membered heterocyclyl; and

each R d is independently optionally substituted C 1 -C 6 alkyl or optionally substituted phenyl; provided that

at least one of R 6 and R 7 , or the optionally substituted C 5 -C 8 carbocyclyl or optionally substituted 5 to 8 membered heterocyclyl formed from R 6 and R 7 and the atoms to which they are attach, comprises a carboxyl; or

R 4 is —NR b R c and at least one of R b and R c comprises a carboxyl or —C(O)OR d .

2. The compound of claim 1 , wherein R 4 is halo or —OS(O) 2 R d , and wherein R d is C 1 -C 6 alkyl or C 1 -C 6 haloalkyl.

3. The compound of claim 1 , wherein R 4 is —NR b R c and the compound is also represented by Formula (IIa) or (IIa′):

or a salt or a mesomeric form thereof.

4. The compound of claim 3 , wherein each of R b and R c is independently H, C 1 -C 6 alkyl, or substituted C 1 -C 6 alkyl, or R b is H and R c is C 1 -C 6 alkyl or substituted C 1 -C 6 alkyl.

5. The compound of claim 4 , wherein the substituted C 1 -C 6 alkyl is independently substituted with carboxyl, —C(O)OR d , sulfo (—SO 3 H), sulfonate (—SO 3 − ), —O—SO 3 − or —SO 2 NR e R f , and wherein each of R e and R f is independently H or C 1 -C 6 alkyl.

6. The compound of claim 4 , wherein each of R b and R c is ethyl.

7. The compound of claim 4 , wherein each of R b and R c is independently C 1 -C 6 alkyl substituted with carboxyl, —C(O)OR d , —SO 3 H, —SO 3 − , or —SO 2 NH 2 .

8. The compound of claim 4 , wherein R b is H and R c is C 1 -C 6 alkyl or C 1 -C 6 alkyl substituted with carboxyl, —C(O)OR d , —SO 3 H, —SO 3 − , —O—SO 3 − or —SO 2 NH 2 .

9. The compound of claim 3 , wherein R b and R c together with the nitrogen atom to which they are attached form an optionally substituted 4, 5 or 6 membered heterocyclyl.

10. The compound of claim 1 , wherein Y is O.

11. The compound of claim 1 , wherein X is S or O.

12. The compound of claim 1 , wherein R 1 is H or C 1 -C 6 alkyl.

13. The compound of claim 1 , wherein R 2 is H.

14. The compound of claim 1 , wherein R 3 is H or C 1 -C 6 alkyl.

15. The compound of claim 1 , wherein R 5 is H.

16. The compound of claim 1 , wherein each of R 6 and R 7 is independently H, C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, optionally substituted phenyl, carboxyl or —C(O)OR d .

17. The compound of claim 16 , wherein one of R 6 or R 7 is H or C 1 -C 6 alkyl, and the other one of R 6 or R 7 is carboxyl, —C(O)OR d , C 1 -C 6 alkyl, substituted C 1 -C 6 alkyl, or phenyl optionally substituted with carboxyl, —C(O)OR d or sulfo.

18. The compound of claim 16 , wherein one of R 6 or R 7 is H or methyl, and the other one of R 6 or R 7 is carboxyl, —C(O)OR d , methyl, phenyl, phenyl substituted with carboxyl or —C(O)OR d , or C 1 -C 6 alkyl substituted with carboxyl or C(O)OR d .

19. The compound of claim 1 , wherein R 6 and R 7 together with the atoms to which they are attached form a C 5 -C 6 carbocyclyl.

20. The compound of claim 1 , selected from the group consisting of

and C 1 -C 6 alkyl carboxylic esters, salts and mesomeric forms thereof.

21. A nucleotide or oligonucleotide labeled with a compound according to claim 3 .

22. A kit comprising a first type of labeled nucleotide according to claim 21 .

23. Use of a labeled nucleotide or oligonucleotide of claim 21 , in sequencing, expression analysis, hybridization analysis, genetic analysis, RNA analysis, or a protein binding assay.

24. A method of determining the sequence of a single-stranded target polynucleotide, comprising:

(a) contacting a primer polynucleotide/target polynucleotide complex with one or more labeled nucleotides, wherein at least one of said labeled nucleotide is a nucleotide of claim 21 , and wherein the primer polynucleotide is complementary to at least a portion of the target polynucleotide;

(b) incorporating a labeled nucleotide into the primer polynucleotide; and

(c) performing one or more fluorescent measurements to determine the identity of the incorporated nucleotide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2022
From: ROMANOV, NIKOLAI NIKOLAEVICH; CALLINGHAM, MICHAEL; ANASTASI, CAROLE; MCCAULEY, PATRICK; HYNES, NIALL; CRAKE, NATASHA; WU, XIAOLIN; LIU, XIAOHAI
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 059522/0198 →
Continuity (2)
Provisional Application 63057758 · Jul 28, 2020
Related Publication 20220033900A1 · Feb 3, 2022